Literature DB >> 23784823

Classification, epidemiology and therapies for testicular germ cell tumours.

Nikhil Vasdev1, Andrew Moon, Andrew C Thorpe.   

Abstract

Testicular germ cell tumours (TGCT) account for between 1% and 1.5% of male neoplasms and 5% of urological tumours in general. They are classified broadly into Seminoma, which resemble primordial germ cells (PGCs), and Non-Seminoma, which are either undifferentiated (embryonal carcinoma) or differentiated (exhibiting a degree of embryonic (teratoma) or extra-embryonic (yolk sac choriocarcinoma) patterning). We present the current details of the latest classification, epidemiology and treatment aspects of TGCT in the UK in our review.

Entities:  

Mesh：

Year:  2013        PMID： 23784823     DOI： 10.1387/ijdb.130031nv

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN： 0214-6282            Impact factor:   2.203


  22 in total

1.  Parent-of-origin effects of A1CF and AGO2 on testicular germ-cell tumors, testicular abnormalities, and fertilization bias.

Authors:  Delphine Carouge; Valerie Blanc; Sue E Knoblaugh; Robert J Hunter; Nicholas O Davidson; Joseph H Nadeau
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-31       Impact factor: 11.205

2.  AXIN1 protects against testicular germ cell tumors via the PI3K/AKT/mTOR signaling pathway.

Authors:  Hailiang Xu; Yunyun Feng; Zhankui Jia; Jinjian Yang; Xueren Lu; Jun Li; Mingliang Xia; Chunru Wu; Yonggang Zhang; Jianhua Chen
Journal:  Oncol Lett       Date:  2017-05-19       Impact factor: 2.967

3.  Association Between RASSF1A Promoter Methylation and Testicular Germ Cell Tumor: A Meta-analysis and a Cohort Study.

Authors:  Dora Markulin; Aleksandar Vojta; Ivana Samaržija; Marija Gamulin; Ivona Bečeheli; Irena Jukić; Čedomir Maglov; Vlatka Zoldoš; Aleksandra Fučić
Journal:  Cancer Genomics Proteomics       Date:  2017 Sep-Oct       Impact factor: 4.069

4.  Adult metastatic yolk sac tumor descending from an intra-abdominal testis: A case report and review of the literature.

Authors:  Zhao Wang; Bin Yan; Yong-Bao Wei; Zhuo Yin; Ke-Qin Zhou; Jin-Rui Yang
Journal:  Oncol Lett       Date:  2015-10-20       Impact factor: 2.967

Review 5.  Systemic therapy for primary and extragonadal germ cell tumors: prognosis and nuances of treatment.

Authors:  Bilal A Siddiqui; Miao Zhang; Louis L Pisters; Shi-Ming Tu
Journal:  Transl Androl Urol       Date:  2020-01

6.  Cabazitaxel overcomes cisplatin resistance in germ cell tumour cells.

Authors:  Mirjam Gerwing; Christine Jacobsen; Sergey Dyshlovoy; Jessica Hauschild; Tina Rohlfing; Christoph Oing; Simone Venz; Jan Oldenburg; Karin Oechsle; Carsten Bokemeyer; Gunhild von Amsberg; Friedemann Honecker
Journal:  J Cancer Res Clin Oncol       Date:  2016-07-16       Impact factor: 4.553

7.  Molecular signatures identified by integrating gene expression and methylation in non-seminoma and seminoma of testicular germ cell tumours.

Authors:  Saurav Mallik; Guimin Qin; Peilin Jia; Zhongming Zhao
Journal:  Epigenetics       Date:  2020-07-13       Impact factor: 4.528

Review 8.  Current Management of Refractory Germ Cell Tumors.

Authors:  Omar Abughanimeh; Benjamin A Teply
Journal:  Curr Oncol Rep       Date:  2021-07-16       Impact factor: 5.075

9.  Successful Treatment with High-Dose Chemotherapy Followed by Autologous Stem-Cell Transplantation in a Patient with Metastatic Germ Cell Tumor.

Authors:  Jung Min Lee; Byung Woog Kang; Man-Hoon Han; Dong Won Baek
Journal:  Case Rep Oncol       Date:  2021-06-24

10.  Malignant testicular tumour incidence and mortality trends.

Authors:  Barbara Stawińska-Witoszyńska; Paulina Wojtyła-Buciora; Barbara Więckowska; Małgorzata Krzywinska-Wiewiorowska; Małgorzata Gromadecka-Sutkiewicz
Journal:  Contemp Oncol (Pozn)       Date:  2016-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.